PreciseDX Aims To ‘Enrich’ Standard Of Care For Breast Cancer Recurrence Prediction

The New York-based augmented intelligence health care services provider has secured $20.7m in series B funding to support clinical validation and commercialization of its AI-powered breast cancer morphology diagnostic test PreciseBreast. The company intends for its test to advance current approaches to recurrence prediction comprising clinician histopathology assessment and genomic testing.

• Source: Shutterstock

PreciseDx will leverage $20.7m in new funding to accelerate validation testing for PreciseBreast, an artificial intelligence (AI)- powered test that analyzes breast cancer cell morphology to predict 6-year risk of recurrence in early-stage breast cancer patients.

Massachusetts-based investment adviser Eventide Asset Management led the series B funding round, PreciseDx announced on 21 August. Other participants included...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Business

Stealth Mode AI Imaging Startup Faction Imaging Raises $10M

 

Faction Imaging has come out of stealth mode following six years of research and development studying medical imaging workflows in India, Japan and the US.

Medtronic Announces Collaboration To Create A ‘New Era’ in Surgical Training

 

Medtronic is teaming up with IRCAD North America to build high-tech training and education experiences for surgeons and medical professionals in cardiovascular, neuroscience, and minimally invasive surgical specialties. The move could also further position Medtronic to seize on the growing robotics

GE HealthCare Launches Intraoperative Ultrasound Product Series: bkActiv S

 

GE HealthCare launches bkActiv S series – part of the bkPortfolio family of Active Imaging systems.